Thiazinamium metilsulfate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C18H23N2S.CH3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IA16WBX317, chemically known as 10h-phenothiazine-10-ethanaminium, n,n,n,alpha-tetramethyl-, methyl sulfate but more generally known as thiazinamium methylsulfate, which bears US NIH Compound Identifier 6015. European Medicines Agency schedules Thiazinamium metilsulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10971MIG. The term THIAZINAMIUM METILSULFATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17). Most nations, for tariff and trade purposes, schedule thiazinamium metilsulfate under HS 29343090 and SITC 51578. As of Q4 2014, THIAZINAMIUM METILSULFATE remains US FDA's Preferred Term for this commodity. Thiazinamium metilsulfate bears US NLM identifiers UMLS ID C2825477 and NCI Concept Code C81151. SMILES: CC(CN1C2CCCCC2SC3C1CCCC3)[N+](C)(C)C.COS(=O)(=O)[O-].